CANTIL (MEPENZOLATE BROMIDE) — FDA Approval NDA010679 (SANOFI AVENTIS US)
CANTIL (MEPENZOLATE BROMIDE) — FDA Approval NDA010679 (SANOFI AVENTIS US) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CANTIL; Active ingredients: MEPENZOLATE BROMIDE; Application number: NDA010679.
| Brand name | CANTIL |
|---|---|
| Active ingredients | MEPENZOLATE BROMIDE |
| Application number | NDA010679 |
| Sponsor | SANOFI AVENTIS US |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 19561114 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →